Atherosclerosis shares many properties with chronic inflammatory diseases including the persistent presence of macrophages. It has been suggested that following their emigration from the blood and transformation into foam cells, macrophage release growth factors which stimulate vascular smooth muscle cell (SMC) proliferation and synthesis of extracellular matrix. However, when macrophage are incubated with modified forms of LDL capable of inducing lipid accumulation, their production of growth factor is reduced. In this application, a radically different approach to the study of macrophage and foam cell release of growth factors is proposed. We hypothesize that the enhanced expression of urokinase-type plasminogen activator (uPA) by foam cells leads to the release of extra-cellular matrix bound growth factors, which stimulate both the proliferation of SMC and their synthesis of matrix.
The specific aims of this proposal are as follows: (i) We will characterize and quantify growth factors released by macrophage and foam cells cultured on intact cell-derived matrices in the presence and absence of plasminogen. Growth factors will be identified by bioassay, immunologic and chromatographic methods. (ii) We will determine the effects of cytokines and growth factors on macrophage and foam cell release of matrix bound growth factors. Cellular release of matrix bound growth factors will be correlated with expression of membrane-bound and secreted uPA activities, as well as uPA mRNA levels. (iii) We will determine the relative roles of fluid-phase and membrane-associated activation of plasminogen in macrophage release of matrix bound growth factors. (iv) We will determine the effect of foam cells on SMC proliferation and matrix synthesis utilizing a direct and indirect coculture systems. (v) Finally, we will evaluate uPA expression by foam cells isolated from atherosclerotic rabbit aortas and human atherectomy- samples by immunohistochemistry and in situ hybridization. The long term objectives of these studies is to identify a mechanism by which macrophage and foam cells stimulate atherosclerotic lesion progression in an effort to provide novel approaches toward intervention.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Pathology A Study Section (PTHA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Weill Medical College of Cornell University
Schools of Medicine
New York
United States
Zip Code
Khan, K M Faisal; Howe, Louise R; Falcone, Domenick J (2004) Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression. J Biol Chem 279:22039-46
Faisal Khan, K M; Laurie, Gordon W; McCaffrey, Timothy A et al. (2002) Exposure of cryptic domains in the alpha 1-chain of laminin-1 by elastase stimulates macrophages urokinase and matrix metalloproteinase-9 expression. J Biol Chem 277:13778-86
Falcone, D J; Borth, W; Khan, K M et al. (2001) Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood 97:777-84
Khan, K M; Falcone, D J (2000) Selective activation of MAPK(erk1/2) by laminin-1 peptide alpha1:Ser(2091)-Arg(2108) regulates macrophage degradative phenotype. J Biol Chem 275:4492-8
Hsu, H Y; Hajjar, D P; Khan, K M et al. (1998) Ligand binding to macrophage scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway. J Biol Chem 273:1240-6
Falcone, D J; Khan, K M; Layne, T et al. (1998) Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen. J Biol Chem 273:31480-5
Khan, K M; Falcone, D J (1997) Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression. J Biol Chem 272:8270-5
Falcone, D J; McCaffrey, T A; Mathew, J et al. (1995) THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor. J Cell Physiol 164:334-43
McCaffrey, T A; Consigli, S; Du, B et al. (1995) Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. J Clin Invest 96:2667-75
Falcone, D J; Borth, W; McCaffrey, T A et al. (1994) Regulation of macrophage receptor-bound plasmin by autoproteolysis. J Biol Chem 269:32660-6

Showing the most recent 10 out of 16 publications